145 related articles for article (PubMed ID: 30541311)
1. Occurrence and Antibiotic Resistance of Enterobacteriaceae in Acute Leukemia Patients.
Simona Z; Ondřej H; Jana P; Patrik M; Jana V; Magdaléna R; Dagmar H; Helena K
Klin Onkol; 2018; 31(4):282-288. PubMed ID: 30541311
[TBL] [Abstract][Full Text] [Related]
2. Multivariate study of enterobacteria and Pseudomonas in saliva of patients with acute leukemia.
Wahlin YB; Granström S; Persson S; Sjöström M
Oral Surg Oral Med Oral Pathol; 1991 Sep; 72(3):300-8. PubMed ID: 1923416
[TBL] [Abstract][Full Text] [Related]
3. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of carbapenemase genes and molecular epidemiology of Enterobacteriaceae strains isolated between 2010-2014 in a university hospitals].
Kutlu HH; Us E; Tekeli A
Mikrobiyol Bul; 2018 Jan; 52(1):1-12. PubMed ID: 29642825
[TBL] [Abstract][Full Text] [Related]
5. Emergence of Enterobacteriaceae co-producing CTX-M-15, ArmA and PMQR in Poland.
Piekarska K; Zacharczuk K; Wołkowicz T; Wolaniuk N; Rzeczkowska M; Gierczyński R
Adv Clin Exp Med; 2019 Feb; 28(2):249-254. PubMed ID: 30499638
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone.
Leski TA; Taitt CR; Bangura U; Stockelman MG; Ansumana R; Cooper WH; Stenger DA; Vora GJ
BMC Infect Dis; 2016 Apr; 16():167. PubMed ID: 27090787
[TBL] [Abstract][Full Text] [Related]
7. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates.
Pena I; Picazo JJ; Rodríguez-Avial C; Rodríguez-Avial I
Int J Antimicrob Agents; 2014 May; 43(5):460-4. PubMed ID: 24657043
[TBL] [Abstract][Full Text] [Related]
8. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06.
Livermore DM; Hope R; Brick G; Lillie M; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii41-54. PubMed ID: 18819979
[TBL] [Abstract][Full Text] [Related]
9. Prevalent mechanisms of resistance among common enterobacterial isolates in Greek hospitals.
Legakis NJ; Maniatis A; Tzouvelekis LS
Microb Drug Resist; 1995; 1(4):331-3. PubMed ID: 9158805
[TBL] [Abstract][Full Text] [Related]
10. Clinical, microbiological and antibiotic susceptibility patterns of diarrhoea in Korem, Ethiopia.
Desenclos JC; Zergabachew A; Desmoulins B; Chouteau L; Desve G; Admassu M
J Trop Med Hyg; 1988 Dec; 91(6):296-301. PubMed ID: 2905012
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Mischnik A; Baumert P; Hamprecht A; Rohde AM; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
J Antimicrob Chemother; 2017 May; 72(5):1359-1363. PubMed ID: 28108677
[TBL] [Abstract][Full Text] [Related]
12. Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe.
Guyomard-Rabenirina S; Malespine J; Ducat C; Sadikalay S; Falord M; Harrois D; Richard V; Dozois C; ; Breurec S; Talarmin A
BMC Microbiol; 2016 Jun; 16(1):121. PubMed ID: 27342199
[TBL] [Abstract][Full Text] [Related]
13. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
[TBL] [Abstract][Full Text] [Related]
14. Activity of plazomicin in combination with other antibiotics against multidrug-resistant Enterobacteriaceae.
Thwaites M; Hall D; Stoneburner A; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C
Diagn Microbiol Infect Dis; 2018 Dec; 92(4):338-345. PubMed ID: 30097297
[TBL] [Abstract][Full Text] [Related]
15. [Beta-lactam and aminoglycoside resistant phenotypes in enterobacteria isolated in pediatrics].
Ben Hassen A; Chourou O; Fendri C; Kammoun A; Ben Redjeb S
Bull Soc Pathol Exot; 1991; 84(2):145-53. PubMed ID: 1914045
[TBL] [Abstract][Full Text] [Related]
16. Gram-negative enteric bacteria in the oral cavity of leukemia patients.
Galili D; Donitza A; Garfunkel A; Sela MN
Oral Surg Oral Med Oral Pathol; 1992 Oct; 74(4):459-62. PubMed ID: 1408020
[TBL] [Abstract][Full Text] [Related]
17. Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates.
Denervaud-Tendon V; Poirel L; Connolly LE; Krause KM; Nordmann P
J Antimicrob Chemother; 2017 Oct; 72(10):2787-2791. PubMed ID: 29091226
[TBL] [Abstract][Full Text] [Related]
18. Use of Fludarabine for the Treatment of Indolent Lymphoma with Chylothorax.
Wild A; Holasová J; Králiková E
Klin Onkol; 2018; 31(4):301-304. PubMed ID: 30541315
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of ceftazidime (GR 20263) against routine hospital isolates and highly resistant strains of enterobacteriaceae and Pseudomonas aeruginosa.
Leigh DA; Nisbet D
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():107-10. PubMed ID: 19802975
[TBL] [Abstract][Full Text] [Related]
20. [Sensitivity profiles of enterobacteria isolated at th Fann University Hospital Center, Dakar].
Sow AI; Faye-Niang MA; Mboup EM; Boye CS; Cisse MF; Ndour CT; Soumare M; Seydi M; Gaye M
Dakar Med; 1997; 42(2):123-6. PubMed ID: 9827134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
